和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

未开盘 10-08 16:08:49

19.620

+1.690

+9.43%

最高19.780	最低17.730	成交量770.32万
今开17.930	昨收17.930	日振幅11.43%
总市值131.85亿	流通市值131.85亿	总股本6.72亿
成交额1.48亿	换手率1.15%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":19.62,"timestamp":1759910929005,"preClose":17.93,"halted":0,"volume":7703150,"delay":0,"floatShares":672000000,"shares":672000000,"eps":0.04858645542335555,"marketStatus":"未开盘","change":1.69,"latestTime":"10-08 16:08:49","open":17.93,"high":19.78,"low":17.73,"amount":147728811,"amplitude":0.114334,"askPrice":19.63,"askSize":1000,"bidPrice":19.62,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.24238372036199796,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759973400000},"marketStatusCode":0,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":17.93,"openAndCloseTimeList":[[1759887000000,1759896000000],[1759899600000,1759910400000]],"volumeRatio":3.4078702882937595,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256","defaultTab":"news","newsList":[{"id":"2573592593","title":"智通港股解盘 | 国庆假期利空偏多黄金持续避险 美巨头合作再度加码AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2573592593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573592593?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:40","pubTimestamp":1759927248,"startTime":"0","endTime":"0","summary":"当地时间10月6日，美国总统特朗普称美国俄勒冈州波特兰市发生“叛乱”，并试图部署国民警卫队。央行数据显示，中国9月末黄金储备报7406万盎司，环比增加4万盎司，为连续第11个月增持黄金。8月末黄金储备报7402万盎司。受此影响，工厂的主要区域已经停产，预计将持续至明年初。巨头之间再度合作加码AI，可见热度会持续提升。协议自双方签订之日起生效，持续到所许可产品的销售特许权期限结束为止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","159934","LU1951186391.HKD","BK4614","IE0008368742.USD","LU1226287875.USD","GDX","BK1163","IE00BZ08YR35.GBP","1OZmain","LU1152091754.HKD","159831","518880","GCmain","LU0880133367.SGD","QOmain","LU1328277881.USD","LU0501845795.SGD","LU1807302812.USD","HSTECH","01177","IE00B5MMRT66.SGD","NUGT","LU0315179316.USD","YANG","MGCmain","BK1191","IE00BZ08YT58.USD","IE0008369823.USD","01618","SGCmain","01093","SG9999002950.SGD","SGUmain","BK1565","02142","BK1521","DUST","LU1226288253.USD","02256","IAU","LU2488822045.USD","SGXZ90724238.SGD","LU1813983027.USD","IE00BZ08YS42.EUR","BK1607"],"gpt_icon":1},{"id":"2573916102","title":"和誉-B(02256)涨6.86% 核心药物匹米替尼中美上市在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2573916102","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573916102?lang=zh_cn&edition=full","pubTime":"2025-10-08 11:16","pubTimestamp":1759893366,"startTime":"0","endTime":"0","summary":"金吾财讯 | 和誉-B 早盘股价震荡走高，截至发稿，仍涨6.86%，报19.16港元，成交额6486.66万港元。招商证券(香港)指出，和誉开发的匹米替尼作为全球疗效最优CSF-1R小分子，即将在中美两地上市，给公司带来持续销售分成。该行认为默克对该分子寄予厚望，有望在全球做到接近15亿美元高峰的销售收入。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1967383","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2573915678","title":"港股异动 | 和誉-B(02256)涨超8%创历史新高 匹米替尼即将上市 有望给公司带来持续销售分成","url":"https://stock-news.laohu8.com/highlight/detail?id=2573915678","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573915678?lang=zh_cn&edition=full","pubTime":"2025-10-08 10:37","pubTimestamp":1759891076,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B(02256)早盘涨超8%，截至发稿，涨8.2%，报19.4港元，成交额5846.51万港元。招商证券国际发表报告称，和誉开发的匹米替尼作为全球疗效最优CSF-1R小分子，即将在中美两地上市，给公司带来持续销售分成。该行认为默克对该分子寄予厚望，有望在全球做到接近15亿美元高峰的销售收入。花旗此前则表示，公司估值仅反映其两款后期候选药物匹米替尼及依帕戈替尼价值，其具高授权潜力的差异化创新药则尚未被市场充分认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","YANG","BK1161","BK4614","LU2488822045.USD","HSCEI"],"gpt_icon":0},{"id":"1148567637","title":"港股部分生物医药股盘中拉升，中国抗体-B、和誉-B涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148567637","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148567637?lang=zh_cn&edition=full","pubTime":"2025-10-08 10:26","pubTimestamp":1759890368,"startTime":"0","endTime":"0","summary":"10月8日，港股部分生物医药股盘中拉升，$中国抗体(03681)$-B、$和誉-B(02256)$涨超7%，$和铂医药-B(02142)$、$维立志博-B(09887)$涨超5%，$九源基因(02566)$涨超4%，$复宏汉霖(02696)$、$加科思-B(01167)$、$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","02256","BK1161","LU2488822045.USD","BK4614","YANG","399441","BK1574","HSTECH","07226","161726","HSCEI"],"gpt_icon":0},{"id":"2573918205","title":"【券商聚焦】招商证券(香港)首予和誉-B(02256)增持评级 看好公司长期发展潜力和高效的小分子开发能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2573918205","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573918205?lang=zh_cn&edition=full","pubTime":"2025-10-08 09:37","pubTimestamp":1759887477,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招商证券 研报指出，在CSF-1R抑制剂的开发中，和誉-B通过高效严谨的临床推进，已经展示了TGCT全球最佳的疗效，安全性和响应率均优于同类分子。该机构认为默克对该分子寄予厚望，有望在全球做到接近15亿美元峰值销售收入。基于合作协议，和誉后续还将获得来自默克的研发里程碑付款及销售里程碑付款，以及上市之后的销售分成。该机构首次覆盖，予以增持评级，预计公司2025-2027年营业收入分别为6.8/5.2/6.3亿元人民币。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1967372","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06099","02256"],"gpt_icon":0},{"id":"2573918562","title":"招商证券香港：首次覆盖和誉-B(02256)予“增持”评级 目标价32.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573918562","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573918562?lang=zh_cn&edition=full","pubTime":"2025-10-08 09:17","pubTimestamp":1759886244,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招商证券香港发布研报称，首次覆盖和誉-B，予以增持评级，通过DCF方法计算，公司合理股权价值为210亿港元，对应未来12个月目标价32.5港元。招商证券香港主要观点如下：商业元年：和誉开发的匹米替尼作为全球疗效最优CSF-1R小分子，即将在中美两地上市，给公司带来持续销售分成。基于合作协议，和誉后续还将获得来自默克的研发里程碑付款及销售里程碑付款，以及上市之后的销售分成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06099","02256"],"gpt_icon":0},{"id":"2573958582","title":"每日卖空追踪 | 和誉-B 10月06日卖空量成交27.5万股，卖空比例为14.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573958582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573958582?lang=zh_cn&edition=full","pubTime":"2025-10-06 16:30","pubTimestamp":1759739427,"startTime":"0","endTime":"0","summary":"和誉-B北京时间10月06日，跌1.05%，卖空量成交27.5万股，较上一交易日增加103.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100616332094bc9745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100616332094bc9745&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2572269385","title":"每日卖空追踪 | 和誉-B 10月02日卖空量成交23.2万股，卖空比例为8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572269385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572269385?lang=zh_cn&edition=full","pubTime":"2025-10-02 16:30","pubTimestamp":1759393829,"startTime":"0","endTime":"0","summary":"和誉-B北京时间10月02日，涨0.56%，卖空量成交23.2万股，较上一交易日减少76.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002163317971cf569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002163317971cf569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2572526931","title":"和誉-B10月02日获主力加仓413.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572526931","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572526931?lang=zh_cn&edition=full","pubTime":"2025-10-02 16:15","pubTimestamp":1759392951,"startTime":"0","endTime":"0","summary":"10月02日, 和誉-B股价涨0.56%，报收18.02元，成交金额5156.2万元，换手率0.43%，振幅3.52%，量比0.94。和誉-B今日主力资金净流入413.0万元，上一交易日主力净流入226.6万元。该股近5个交易日上涨2.97%，主力资金累计净流入519.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3456.4万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002162014a6aae5c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002162014a6aae5c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2572732028","title":"和誉-B09月30日主力净流入226.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2572732028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572732028?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220128,"startTime":"0","endTime":"0","summary":"09月30日, 和誉-B股价涨2.40%，报收17.92元，成交金额5194.5万元，换手率0.43%，振幅5.14%，量比0.96。和誉-B今日主力资金净流入226.6万元，上一交易日主力净流出146.2万元。该股近5个交易日上涨2.56%，主力资金累计净流入329.5万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3328.1万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930161718a44e1d91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930161718a44e1d91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2571321523","title":"和誉-B(02256)授出 634.35万份购股权及460.64万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2571321523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571321523?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:23","pubTimestamp":1759155827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，本公司于2025年9月29日根据首次公开发售后购股权计划授出 634.35万份购股权(购股权)予本公司的三名董事(董事)及若干雇员(合称“购股权承授人”)，惟须待购股权承授人接纳方可作实。本公司于2025年9月29日根据2019年股权激励计划授出460.64万份受限制股份单位(受限制股份单位)予本公司的若干雇员(受限制股份单位承授人)，惟须待受限制股份单位承授人接纳方可作实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2571686493","title":"每日卖空追踪 | 和誉-B 09月29日卖空量成交4.5万股，卖空比例为2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571686493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571686493?lang=zh_cn&edition=full","pubTime":"2025-09-29 16:30","pubTimestamp":1759134630,"startTime":"0","endTime":"0","summary":"和誉-B北京时间09月29日，涨3.24%，卖空量成交4.5万股，较上一交易日减少84.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163400954be6e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163400954be6e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2570853404","title":"每日卖空追踪 | 和誉-B 09月26日卖空量成交21.2万股，卖空比例为4.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570853404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570853404?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:30","pubTimestamp":1758875428,"startTime":"0","endTime":"0","summary":"和誉-B北京时间09月26日，跌1.63%，卖空量成交21.2万股，较上一交易日增加35.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926163338a69f9bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926163338a69f9bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2569702337","title":"每日卖空追踪 | 和誉-B 09月24日卖空量成交18.8万股，卖空比例为4.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569702337","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569702337?lang=zh_cn&edition=full","pubTime":"2025-09-24 16:30","pubTimestamp":1758702626,"startTime":"0","endTime":"0","summary":"和誉-B北京时间09月24日，跌2.72%，卖空量成交18.8万股，较上一交易日减少49.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417245295421dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417245295421dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2569275790","title":"大摩：市场对生物科技股认可度提升 推动股价跑赢大市 看好康方生物(09926)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2569275790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569275790?lang=zh_cn&edition=full","pubTime":"2025-09-23 09:47","pubTimestamp":1758592020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹发布研报称，在港上市的中国生物科技股总市值由年初至今累升154%，远超恒指同期的34%升幅，相信是反映了市场对本土药企创新能力的认可度发生重大转变，预期美联储加快减息步伐将推动风险偏好调整，推动资金流向中国生物科技等增长型板块。惟大摩预期，个别股分表现仍取决于公司基本面，包括商业化执行力及创新研发进度，看好具短期催化剂的公司，如康方生物(09926)、诺诚健华(09969)、和誉-B(02256)、信达生物(01801)、映恩生物-B(09606)等，另外亦给予维升药业-B(02561)及再鼎医药(09688)“跑赢大市”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0561508036.HKD","IE00B5MMRT66.SGD","LU2097828557.USD","LU2097828474.EUR","LU0348735423.USD","LU0348783233.USD","LU0417516902.SGD","BK1583","LU2476274720.SGD","09926","159837","02561","LU0348766576.USD","LU2328871848.SGD","LU2097828631.EUR","HK0000252160.HKD","LU0348784397.USD","LU0417516738.SGD","LU0348825331.USD","IE00B543WZ88.USD","LU0634319403.HKD","09969","LU0455707207.USD","LU0417516571.SGD","BK1574","LU1969619763.USD","LU2242644610.SGD","BK1589","LU2488822045.USD","LU0348827113.USD","LU0540923850.HKD","IE00BPRC5H50.USD","HK0000252152.HKD","02256","BK1161","LU2097828805.USD","LU2476274308.USD","09606","HK0000500386.USD","LU2778985437.USD","LU0502904849.HKD","LU2097828714.EUR","LU0348767384.USD","LU1794554557.SGD","LU1720050803.USD","01801","LU2543165471.USD"],"gpt_icon":0},{"id":"2569736182","title":"每日卖空追踪 | 和誉-B 09月22日卖空量成交12.2万股，卖空比例为5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569736182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569736182?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:30","pubTimestamp":1758529830,"startTime":"0","endTime":"0","summary":"和誉-B北京时间09月22日，涨2.01%，卖空量成交12.2万股，较上一交易日减少98.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163420953d6d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922163420953d6d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2569946736","title":"和誉-B09月22日获主力加仓154.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569946736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569946736?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:15","pubTimestamp":1758528944,"startTime":"0","endTime":"0","summary":"09月22日, 和誉-B股价涨2.01%，报收17.80元，成交金额3899.1万元，换手率0.33%，振幅6.02%，量比0.33。和誉-B今日主力资金净流入154.1万元，连续4日净流入，上一交易日主力净流入266.9万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为16.67%，平均涨幅为2.16%。该股近5个交易日下跌0.95%，主力资金累计净流入844.4万元；近20日主力资金累计净流入4103.3万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922161930a43bec95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922161930a43bec95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2569058182","title":"【券商聚焦】兴业证券首予和誉-B(02256)“增持”评级 指差异化小分子创新药逐步进入兑现周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2569058182","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569058182?lang=zh_cn&edition=full","pubTime":"2025-09-22 13:55","pubTimestamp":1758520553,"startTime":"0","endTime":"0","summary":"金吾财讯 | 兴业证券研报指出，和誉-B 上半年实现收入人民币6.12亿元，同比增长23%；实现期内利润人民币3.28亿元，同比增长59%。公司于2025年5月收到默克的全球商业化选择权行权费6.12亿人民币。截至2025年6月30日，公司的现金及银行结余为人民币23.32亿元，在手现金充沛。2025年6月，公司已完成依帕戈替尼的注册性研究的首例患者给药。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1966598","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","601377"],"gpt_icon":0},{"id":"2568321675","title":"每日卖空追踪 | 和誉-B 09月19日卖空量成交27万股，卖空比例为8.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568321675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568321675?lang=zh_cn&edition=full","pubTime":"2025-09-19 16:30","pubTimestamp":1758270629,"startTime":"0","endTime":"0","summary":"和誉-B北京时间09月19日，跌0.23%，卖空量成交27万股，较上一交易日减少46.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919163350a436bfa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919163350a436bfa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2568739239","title":"【券商聚焦】申万宏源首予和誉-B(02256)“买入”评级 指公司将进入“自我造血”的良性循环","url":"https://stock-news.laohu8.com/highlight/detail?id=2568739239","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568739239?lang=zh_cn&edition=full","pubTime":"2025-09-19 12:21","pubTimestamp":1758255674,"startTime":"0","endTime":"0","summary":"匹米替尼已在中国递交NDA申请，预计2026年上市，将成为公司首款商业化产品。未来随着对外授权合作不断达成，产品商业化放量，公司将进入“自我造血”的良性循环。上市后中国、美国市场均将由默克进行商业化销售。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1966498","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000166","02256"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":0.0949},{"period":"1month","weight":0.084},{"period":"3month","weight":1.0144},{"period":"6month","weight":1.8726},{"period":"1year","weight":4.2742},{"period":"ytd","weight":3.2652}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1166},{"period":"6month","weight":0.2828},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.3375}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.143011},{"month":2,"riseRate":0.75,"avgChangeRate":0.046576},{"month":3,"riseRate":0.5,"avgChangeRate":0.054417},{"month":4,"riseRate":0.25,"avgChangeRate":-0.010041},{"month":5,"riseRate":0.25,"avgChangeRate":0.029375},{"month":6,"riseRate":0.5,"avgChangeRate":0.006841},{"month":7,"riseRate":0.75,"avgChangeRate":0.047273},{"month":8,"riseRate":0.5,"avgChangeRate":0.114048},{"month":9,"riseRate":0.75,"avgChangeRate":0.043844},{"month":10,"riseRate":0.75,"avgChangeRate":0.027455},{"month":11,"riseRate":0.75,"avgChangeRate":0.204437},{"month":12,"riseRate":0,"avgChangeRate":-0.093315}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}